These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 36053612)

  • 1. Optimising neonatal antiretroviral therapy using raltegravir: a qualitative analysis of healthcare workers' and caregivers' perspectives.
    Katirayi L; Stecker C; Andifasi P; Mushavi A; Tiwari P; Jakazi C; Maphosa T; Thorsen V; Murandu M; Gombakomba G; Mungati M; Denoeud-Ndam L; Rivadeneira E; Weber R; Hrapcak S
    BMJ Paediatr Open; 2022 Jul; 6(1):. PubMed ID: 36053612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation and Uptake of Raltegravir Granules in Newborns Diagnosed With HIV Through Birth Testing in Maternity Settings in Zimbabwe During the COVID-19 Pandemic.
    Denoeud-Ndam L; Stecker C; Andifasi P; Mushavi A; Maphosa T; Zondo M; Murandu M; Gombakomba G; Katirayi L; Mungati M; Bailey R; Weber R; Rivadeneira E; Hrapcak S
    Pediatr Infect Dis J; 2023 Jul; 42(7):573-575. PubMed ID: 37000925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability and Feasibility of Using Raltegravir Oral Granules for the Treatment of Neonates in a Low-resource Setting.
    Archary M; Zanoni B; Lallemant M; Suwannaprom P; Clarke D; Penazzato M
    Pediatr Infect Dis J; 2020 Jan; 39(1):57-60. PubMed ID: 31815839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'There are no more secrets': acceptability of a family-centered model of care for HIV positive children in Eswatini.
    Khumalo PN; Katirayi L; Ashburn K; Chouraya C; Mpango L; Mthethwa N; Mofenson LM
    BMC Health Serv Res; 2020 Oct; 20(1):951. PubMed ID: 33059670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study.
    Katirayi L; Namadingo H; Phiri M; Bobrow EA; Ahimbisibwe A; Berhan AY; Buono N; Moland KM; Tylleskär T
    J Int AIDS Soc; 2016; 19(1):20919. PubMed ID: 27312984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shifting human resources for health in the context of ART provision: qualitative and quantitative findings from the Lablite baseline study.
    Nkhata MJ; Muzambi M; Ford D; Chan AK; Abongomera G; Namata H; Mambule I; South A; Revill P; Grundy C; Mabugu T; Chiwaula L; Hakim J; Kityo C; Reid A; Katabira E; Sodhi S; Gilks CF; Gibb DM; Seeley J; Cataldo F;
    BMC Health Serv Res; 2016 Nov; 16(1):660. PubMed ID: 27852291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'The baby will have the right beginning': a qualitative study on mother and health worker views on point-of-care HIV birth testing across 10 sites in Zimbabwe.
    Sacks E; Katirayi L; Kaeberle B; Mafaune HW; Chadambuka A; Tachiwenyika E; Nyamundaya T; Cohn J; Mahomva A; Mushavi A
    BMC Pediatr; 2022 Sep; 22(1):546. PubMed ID: 36104687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of raltegravir-based therapy to induce rapid viral decay in highly viraemic HIV-infected neonates.
    Ripamonti D; Tatarelli P; Mangili G; Gotta C; Benatti SV; Bruzzone B; Callegaro A; Viscoli C; Ruggeri M; Di Biagio A
    J Chemother; 2016 Aug; 28(4):337-40. PubMed ID: 25248795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief Report: Pediatric Saliva-Based HIV Testing: Health care Worker and Caregiver Acceptability.
    Neary J; Bulterys MA; Ogutu EA; O'Malley G; Otieno AA; Omondi VO; Wang Y; Zhai X; Katz DA; Oyiengo L; Wamalwa DC; Slyker JA; John-Stewart GC; Njuguna IN; Wagner AD
    J Acquir Immune Defic Syndr; 2022 Aug; 90(5):517-523. PubMed ID: 35499505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Health Literate Patient-focused Approach to the Redesign of the Raltegravir (ISENTRESS) Pediatric Kit and Instructions for Use.
    Mills A; Myers L; Raudenbush C; Vossen DA; Teppler H; Miteva YR; Seeley S; Homony B; Straus WL
    Pediatr Infect Dis J; 2022 Jan; 41(1):51-56. PubMed ID: 34694252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-training and mentorship experiences of KidzAlive-trained healthcare workers at primary healthcare facilities in KwaZulu-Natal, South Africa.
    Mutambo C; Shumba K; Hlongwana KW
    Afr J Prim Health Care Fam Med; 2020 Jun; 12(1):e1-e11. PubMed ID: 32634017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term immunologic and virologic responses on raltegravir-containing regimens among ART-experienced participants in the HIV Outpatient Study.
    Buchacz K; Wiegand R; Armon C; Chmiel JS; Wood K; Brooks JT; Palella FJ
    HIV Clin Trials; 2015 Aug; 16(4):139-46. PubMed ID: 26126549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus-Infected Patients With Nonalcoholic Fatty Liver Disease.
    Macías J; Mancebo M; Merino D; Téllez F; Montes-Ramírez ML; Pulido F; Rivero-Juárez A; Raffo M; Pérez-Pérez M; Merchante N; Cotarelo M; Pineda JA;
    Clin Infect Dis; 2017 Sep; 65(6):1012-1019. PubMed ID: 28903510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110.
    Clarke DF; Mirochnick M; Acosta EP; Capparelli E; Chain A; Teppler H; Smith B; Lommerse J;
    J Acquir Immune Defic Syndr; 2019 Dec; 82(4):392-398. PubMed ID: 31658182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "The right time is just after birth": acceptability of point-of-care birth testing in Eswatini: qualitative results from infant caregivers, health care workers, and policymakers.
    Sacks E; Khumalo P; Tsabedze B; Montgomery W; Mthethwa N; Nhlabatsi B; Masuku T; Cohn J; Chouraya C
    BMC Pediatr; 2020 Jul; 20(1):347. PubMed ID: 32669131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetic profile of raltegravir-containing antiretroviral therapy in HIV-infected individuals over 60 years of age.
    Vera JH; Jackson A; Dickinson L; Else L; Barber T; Mora-Peris B; Back D; Boffito M; Winston A
    HIV Clin Trials; 2015; 16(1):39-42. PubMed ID: 25777188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telling Children with Perinatal HIV About Their HIV Serostatus: Healthcare Workers' Practices and Barriers to Disclosing in a South African Rural Health District.
    Madiba S; Diko C
    J Prim Care Community Health; 2021; 12():2150132720984757. PubMed ID: 33601930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study.
    Moreira FL; Marques MP; Duarte G; Lanchote VL
    J Pharm Biomed Anal; 2020 Jan; 177():112838. PubMed ID: 31525573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens.
    Cozzi-Lepri A; Zangerle R; Machala L; Zilmer K; Ristola M; Pradier C; Kirk O; Sambatakou H; Fätkenheuer G; Yust I; Schmid P; Gottfredsson M; Khromova I; Jilich D; Flisiak R; Smidt J; Rozentale B; Radoi R; Losso MH; Lundgren JD; Mocroft A;
    HIV Med; 2018 Feb; 19(2):102-117. PubMed ID: 28984429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health workers' views on factors affecting caregiver engagement with bubble CPAP.
    Salimu S; Kinshella MW; Vidler M; Banda M; Newberry L; Dube Q; Molyneux EM; Goldfarb DM; Kawaza K; Nyondo-Mipando AL
    BMC Pediatr; 2020 Apr; 20(1):180. PubMed ID: 32326900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.